Compare Stocks: STXS, KSCP, and PRCT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KSCP Knightscope	$1.41 +5.2%	$1.60	$1.32 ▼ $7.62	$31.26M	1.28	795,886 shs	675,542 shs
PRCT PROCEPT BioRobotics	$21.37 -2.7%	$20.35	$16.67 ▼ $41.51	$1.26B	0.91	1.12 million shs	861,034 shs
STXS Stereotaxis	$1.39 +0.7%	$1.50	$1.24 ▼ $3.59	$138.28M	1.43	568,136 shs	399,305 shs

10 Best Stocks to Own - Summer 2026

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KSCP Knightscope	+5.22%	0.00%	-12.96%	-38.43%	-75.04%
PRCT PROCEPT BioRobotics	-2.73%	+3.74%	+16.90%	-23.21%	-43.53%
STXS Stereotaxis	+0.72%	-5.44%	-2.11%	-21.91%	-48.71%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
KSCP Knightscope	$1.41 +5.2%	$1.60	$1.32 ▼ $7.62	$31.26M	1.28	795,886 shs	675,542 shs
PRCT PROCEPT BioRobotics	$21.37 -2.7%	$20.35	$16.67 ▼ $41.51	$1.26B	0.91	1.12 million shs	861,034 shs
STXS Stereotaxis	$1.39 +0.7%	$1.50	$1.24 ▼ $3.59	$138.28M	1.43	568,136 shs	399,305 shs

10 Best Stocks to Own - Summer 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
KSCP Knightscope	+5.22%	0.00%	-12.96%	-38.43%	-75.04%
PRCT PROCEPT BioRobotics	-2.73%	+3.74%	+16.90%	-23.21%	-43.53%
STXS Stereotaxis	+0.72%	-5.44%	-2.11%	-21.91%	-48.71%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
KSCP Knightscope	2.50	Moderate Buy	$12.67	798.35% Upside
PRCT PROCEPT BioRobotics	2.19	Hold	$25.09	17.41% Upside
STXS Stereotaxis	3.00	Buy	$3.50	151.80% Upside

Current Analyst Ratings Breakdown

Latest STXS, KSCP, and PRCT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/27/2026	STXS Stereotaxis	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/27/2026	STXS Stereotaxis	Citizens Jmp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Market Outperform	$4.00 ➝ $3.00
8/13/2026	KSCP Knightscope	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$8.00 ➝ $3.00
8/12/2026	STXS Stereotaxis	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$5.00 ➝ $3.00
8/5/2026	PRCT PROCEPT BioRobotics	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$34.00 ➝ $28.00
8/5/2026	PRCT PROCEPT BioRobotics	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$21.00
8/5/2026	PRCT PROCEPT BioRobotics	Evercore Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$23.00
8/5/2026	PRCT PROCEPT BioRobotics	Robert W. Baird Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$20.00
8/5/2026	PRCT PROCEPT BioRobotics	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$35.00 ➝ $25.00
8/5/2026	PRCT PROCEPT BioRobotics	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold	$20.00
8/5/2026	PRCT PROCEPT BioRobotics	William Blair Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform

(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
KSCP Knightscope	$11.34M	2.90	N/A	N/A	$1.27 per share	1.11
PRCT PROCEPT BioRobotics	$308.05M	3.97	N/A	N/A	$5.94 per share	3.60
STXS Stereotaxis	$32.38M	4.30	N/A	N/A	$0.12 per share	11.58

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
KSCP Knightscope	-$33.81M	-$3.43	N/A	N/A	N/A	-217.29%	-152.20%	-90.99%	11/11/2026 (Estimated)
PRCT PROCEPT BioRobotics	-$95.57M	-$1.94	N/A	N/A	N/A	-32.53%	-30.62%	-22.10%	11/3/2026 (Estimated)
STXS Stereotaxis	-$21.64M	-$0.28	N/A	N/A	N/A	-74.24%	-130.84%	-29.23%	11/10/2026 (Estimated)

Latest STXS, KSCP, and PRCT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2026	Q2 2026	KSCP Knightscope	-$0.6650	-$0.79	-$0.1250	-$0.79	$9.00 million	$9.02 million
8/11/2026	Q2 2026	STXS Stereotaxis	-$0.05	-$0.05	N/A	-$0.05	$8.35 million	$7.67 million
8/4/2026	Q2 2026	PRCT PROCEPT BioRobotics	-$0.4619	-$0.47	-$0.0081	-$0.47	$92.77 million	$94.50 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
KSCP Knightscope	N/A	N/A	N/A	N/A	N/A
PRCT PROCEPT BioRobotics	N/A	N/A	N/A	N/A	N/A
STXS Stereotaxis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
KSCP Knightscope	0.14	1.16	0.98
PRCT PROCEPT BioRobotics	0.15	6.55	5.35
STXS Stereotaxis	N/A	1.42	0.95

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
KSCP Knightscope	14.61%
PRCT PROCEPT BioRobotics	89.46%
STXS Stereotaxis	45.35%

Insider Ownership

Company	Insider Ownership
KSCP Knightscope	1.75%
PRCT PROCEPT BioRobotics	4.00%
STXS Stereotaxis	16.03%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
KSCP Knightscope	40	23.33 million	22.92 million	Not Optionable
PRCT PROCEPT BioRobotics	430	57.27 million	54.98 million	Optionable
STXS Stereotaxis	130	100.20 million	84.14 million	Not Optionable

STXS, KSCP, and PRCT Headlines

Recent News About These Companies

University of Szeged Celebrates Strongest First Month of Robotic Cardiology Program

September 3 at 7:56 AM | globenewswire.com

Stereotaxis, Inc. (STXS) Stock Price, News, Quote & History - Yahoo Finance

September 1 at 8:10 PM | finance.yahoo.com

Citizens Jmp Lowers Stereotaxis (NYSEAMERICAN:STXS) Price Target to $3.00

August 29, 2026 | americanbankingnews.com

Citizens Jmp Issues Pessimistic Forecast for Stereotaxis (NYSEAMERICAN:STXS) Stock Price

August 27, 2026 | marketbeat.com

Stereotaxis (STXS) Q2 2026 Earnings Call Transcript

August 19, 2026 | finance.yahoo.com

Stereotaxis misses on Q2 revenue, cuts back 2026 guidance

August 13, 2026 | massdevice.com

Stereotaxis (NYSEAMERICAN:STXS) Releases Quarterly Earnings Results, Meets Estimates

August 12, 2026 | marketbeat.com

TD Cowen Has Lowered Expectations for Stereotaxis (NYSEAMERICAN:STXS) Stock Price

August 12, 2026 | marketbeat.com

Stereotaxis, Inc.: Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

August 12, 2026 | finanznachrichten.de

Stereotaxis expects recurring revenue to reach $8M in Q4 2026 as MAGiC adoption remains supply constrained

August 12, 2026 | seekingalpha.com

Stereotaxis, Inc. (STXS) Q2 2026 Earnings Call Transcript

August 11, 2026 | seekingalpha.com

Stereotaxis Q2 Earnings Call Highlights

August 11, 2026 | marketbeat.com

Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2026 | zacks.com

Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates

August 11, 2026 | globenewswire.com

Stereotaxis, Inc. (STXS) latest stock news and headlines – Yahoo Finance

August 10, 2026 | uk.finance.yahoo.com

Stereotaxis to Report Second Quarter 2026 Financial Results on August 11, 2026

July 21, 2026 | markets.businessinsider.com

Stereotaxis, Inc.: University of Szeged Pioneers First Robotic Cardiology Program in Hungary

July 20, 2026 | finanznachrichten.de

Stereotaxis (STXS) Could Be 56% Undervalued After Shelf Registration Filings

July 20, 2026 | finance.yahoo.com

University of Szeged Pioneers First Robotic Cardiology Program in Hungary

July 20, 2026 | globenewswire.com

STXS Share News Today

July 9, 2026 | uk.investing.com

Stereotaxis Completes Acquisition of Robocath

July 9, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

STXS, KSCP, and PRCT Company Descriptions

Knightscope NASDAQ:KSCP

$1.41 +0.07 (+5.22%)

As of 09/3/2026 04:00 PM Eastern

Knightscope, Inc. designs, develops, manufactures, markets, deploys, and supports autonomous security robots (ASR) in the United States. Its products include K3 and K5 ASRs designed to roam a geo-fenced area autonomously by utilizing numerous sensors and lasers, either on a random basis or based on a particular patrolling algorithm to navigate around people, vehicles, and objects in dynamic indoor or outdoor environments; K1, an ASR for used in indoors or outdoors and at ingress/egress points for both people and vehicles; and K7, a multi-terrain ASR. The company also develops and operates the Knightscope security operations center (KSOC), a browser-based interface, which allows real-time data access service to its clients for alert of an abnormal event; and Knightscope network operations center (KNOC), a custom set of tools that enables it to manage and monitor the network of ASRs with alerts related to critical indicators and statistics, including charging, software, navigation, and temperatures, as well as to execute over-the-air software upgrades, patches, and other related items. In addition, it offers Knightscope+, a virtual monitoring and response solution that provides an alternative for client sites. The company serves airports, commercial real estate, corporate campus, homeowner associations, hotels, universities, municipalities, rail, healthcare, public parks, schools, casinos, corporations, logistics, manufacturing, law enforcement, Parking areas, municipalities, universities, and property management companies, as well as the U.S. federal government. Knightscope, Inc. was incorporated in 2013 and is headquartered in Mountain View, California.

PROCEPT BioRobotics NASDAQ:PRCT

$21.37 -0.60 (-2.73%)

As of 09/3/2026 04:00 PM Eastern

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Stereotaxis NYSEAMERICAN:STXS

$1.39 +0.01 (+0.72%)

As of 09/3/2026 04:10 PM Eastern

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STXS, KSCP, and PRCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STXS, KSCP, and PRCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STXS, KSCP, and PRCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

STXS, KSCP, and PRCT Company Descriptions

Knightscope NASDAQ:KSCP

PROCEPT BioRobotics NASDAQ:PRCT

Stereotaxis NYSEAMERICAN:STXS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest STXS, KSCP, and PRCT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest STXS, KSCP, and PRCT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

STXS, KSCP, and PRCT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

STXS, KSCP, and PRCT Company Descriptions

Knightscope NASDAQ:KSCP

PROCEPT BioRobotics NASDAQ:PRCT

Stereotaxis NYSEAMERICAN:STXS

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools